Nothing Special   »   [go: up one dir, main page]

Zhang et al., 1994 - Google Patents

Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.

Zhang et al., 1994

View PDF
Document ID
11754792964157230396
Author
Zhang W
Lachmann P
Publication year
Publication venue
Immunology

External Links

Snippet

To investigate the effect of carbohydrate on activation of the alternative pathway of complement by IgA immune complexes, aglycosylated monoclonal IgA was made biosynthetically in the presence of tunicamycin. When immune complexes were incubated …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2

Similar Documents

Publication Publication Date Title
Zhang et al. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
Winkelhake et al. Aglycosylantibody. Effects of exoglycosidase treatments on autochthonous antibody survival time in the circulation.
Kobata The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles
Bindon et al. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
US6218149B1 (en) Antibodies having modified carbohydrate content and methods of preparation and use
Walker et al. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing FcγRI and/or FcγRII receptors
Diamond et al. A new Fc receptor on mouse macrophages binding IgG3.
García-González et al. Purification of murine IgG3 and IgM monoclonal antibodies by euglobulin precipitation
Young Jr et al. Staphylococcal protein A binding to the Fab fragments of mouse monoclonal antibodies.
Shibuya et al. One-step purification of murine IgM and human α2-macroglobulin by affinity chromatography on immobilized snowdrop bulb lectin
Ishizaka et al. Demonstration of Fcγ receptors on human basophil granulocytes
Woof et al. The monocyte binding domain (s) on human immunoglobulin G
Ware et al. A rat anti-mouse kappa chain specific monoclonal antibody, 187.1. 10: purification, immunochemical properties and its utility as a general second-antibody reagent
Conrad et al. Properties of two monoclonal antibodies directed against the Fc and Fab′ regions of rat IgE
Woodard et al. Characterization of epitopes of human secretory component on free secretory component, secretory IgA, and membrane-associated secretory component.
Bindon et al. Complement activation by immunoglobulin does not depend solely on C1q binding
Coloma et al. The role of carbohydrate in the assembly and function of polymeric IgG
Avrameas et al. A quantitative study at the single cell level of immunoglobulin antigenic determinants present on the surface of murine B and T lymphocytes
Leibiger et al. Glycosylation analysis of a polyreactive human monoclonal IgG antibody derived from a human-mouse heterohybridoma
Lundblad et al. Radioimmunoassay of a glucose-containing tetrasaccharide using a monoclonal antibody
Unkeless et al. Fc receptors on mouse macrophages
EP1442063A2 (en) Anti-n-glycolyl-neuraminic acid antibodies and their use for identifying glycoproteins
KooLWIJK et al. Binding of the human complement subcomponent C1q to hybrid mouse monoclonal antibodies
EP3941480A1 (en) Compounds for inhibiting fucosylation and methods for using the same
KREMMER et al. Monoclonal antibodies to complement components without the need of their prior purification. II. Antibodies to mouse C3 and C4